Researchers analyzed data from 1,434 patients with mediastinal disorders to compare two types of procedures: EBUS-TBNB (core biopsy) and EBUS-TBNA (needle aspiration). The study looked at how well each method identified conditions such as lung cancer, lymphoma, and sarcoidosis.
The results showed that the core biopsy method had a higher diagnostic yield than needle aspiration overall. Specifically, it performed significantly better for patients with lymphoma and sarcoidosis. However, there was no significant difference between the two methods when diagnosing lung cancer.
Both procedures were found to be safe, with low complication rates and no deaths reported during the procedures. While the core biopsy may have a diagnostic advantage for certain conditions, it is important to note that much of the evidence comes from observational studies rather than randomized trials. Patients should discuss these specific findings with their doctors to determine the best approach for their individual diagnosis.
